Morning Buzz: Zafgen (ZFGN), Xilinx (XLNX), Plexus Corp. (PLXS), Barclays (BCS)

wall street

Zafgen, Inc. (ZFGN) shares continue to skyrocket on positive obesity drug results. The name is higher by more than 12% to $11.25 in pre-market trading on Thursday.

ZFGN soared 70% to $11.88 on Wednesday.

Xilinx Inc. (XLNX) shares surged 10% to $47.38 in late morning trading after the chipmaker matched estimates with Q3 profit of $0.49 per share on revenues of $566 million. Analysts were expecting revenues of $554.5 million. The move comes on a big volume too with the issue currently trading more than 5 million shares, compared to the average daily volume of 2.8 million shares.

Plexus Corp. (PLXS) reported first-quarter EPS of $0.47 before the opening bell Thursday, compared to the consensus estimate of $0.45. Revenues decreased 7.2% from last year to $617 million. Analysts expected revenues of $608.86 million. The stock is currently up $4.09 to $33.72 on 450K shares.

Barclays (BCS) – Bloomberg reports the London-based banking giant will cut about 1,200 jobs in its investment banking business, and shut securities operations across Asia.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.